English
Home > Products > Selenium API

China Selenium API Factory

Having a sound small business credit score, outstanding after-sales services and modern manufacturing facilities, we've got earned an fantastic reputation among our buyers across the globe for Selenium API,CAS NO 7488-56-4,7488-56-4,Selenium, You should send us your specifications and requirements, or feel totally free to speak to us with any questions or inquiries that you may have.
Selenium API, Relying on superior quality and excellent post-sales, our items sell well in America, Europe, the Middle East and South Africa. We're also the appointed OEM factory for several worlds' famous merchandise brands. Welcome to contact us for further negotiation and cooperation.

Related Products

Hot Products

  • Lumateperone

    Lumateperone

    Product Name:Lumateperone
    Molecular Formula:C24H28FN3O
    Molecular Weight:393.5
    CAS Registry Number;313368-91-1
  • Propacetamol hydrochloride

    Propacetamol hydrochloride

    Product Name:Propacetamol hydrochloride
    Molecular Formula:C14H21ClN2O3
    Molecular Weight;300.78
    CAS Registry Number;66532-86-3
  • Ropivacaine hydrochloride

    Ropivacaine hydrochloride

    Product Name:Ropivacaine hydrochloride
    Molecular Formula:C17H26N2O.ClH.H2O
    Molecular Weight;328.88
    CAS Registry Number;132112-35-7
  • SODIUM 2,6-DIFLUOROBENZOATE

    SODIUM 2,6-DIFLUOROBENZOATE

    Product Name:SODIUM 2,6-DIFLUOROBENZOATE
    Molecular Formula:C7H3F2NaO2
    Molecular Weight:180.0840964
    CAS Registry Number:6185-28-0
  • 5-Nitro-2-furaldehyde diacetate

    5-Nitro-2-furaldehyde diacetate

    Product Name:5-Nitro-2-furaldehyde diacetate
    Molecular Formula:C9H9NO7
    Molecular Weight:243.17
    CAS Registry Number:92-55-7
  • Ethanone, 1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)-

    Ethanone, 1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)-

    Product Name:Ethanone, 1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)-
    Molecular Formula:C9H7ClN4O
    Molecular Weight:222.63
    CAS Registry Number:1259059-71-6
  • Related Blog
  • Reviews

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept